# Crosstalk Therapeutics (Crosstalk Therapeutics Ltd)

Private limited company registered in Sandwich, classed under “Research and experimental development on biotechnology”.

- Company number: 13162770
- Status: Active
- Type: Private limited company
- Incorporated: 27 January 2021
- Registered office: Innovation House Innovation Way, Discovery Park, Sandwich, Kent, CT13 9FF
- Location: Sandwich, Kent
- Activity: Research and experimental development on biotechnology

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Crosstalk Therapeutics do?

Private limited company registered in Sandwich, classed under “Research and experimental development on biotechnology”.

### How much turnover does Crosstalk Therapeutics make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/crosstalk-therapeutics-13162770

### Is Crosstalk Therapeutics profitable?

Crosstalk Therapeutics's profit isn't public: small companies may file without a profit and loss account.

### How many people work at Crosstalk Therapeutics?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/crosstalk-therapeutics-13162770

### Who runs and owns Crosstalk Therapeutics?

Its directors are Michael President Gladstone, Jernej Godec, Nicholas Alexander Williams. Its owners are shown to subscribers.

### Where is Crosstalk Therapeutics based?

Its registered office is Innovation House Innovation Way, Discovery Park, Sandwich, Kent, CT13 9FF, in Sandwich, Kent.

### When was Crosstalk Therapeutics founded?

Crosstalk Therapeutics Ltd was incorporated on 27 January 2021.

### Is Crosstalk Therapeutics still trading?

The register lists Crosstalk Therapeutics Ltd as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-07-06: Total exemption full accounts made up to 31 December 2025
- 2025-09-30: Accounts for a small company made up to 31 December 2024
- 2025-03-13: Director's details changed for Mr Nicholas Alexander Williams on 28 January 2025
- 2025-03-12: Notification of a person with significant control statement
- 2025-03-12: Cessation of Medicxi Iii Lp as a person with significant control on 20 June 2024
- 2024-11-01: Accounts for a small company made up to 31 December 2023
- 2024-08-15: Previous accounting period shortened from 31 January 2024 to 31 December 2023
- 2024-07-17: Statement of capital following an allotment of shares on 20 June 2024 · GBP 442.5609 (and 1 more like it since 16 July 2024)
- 2024-07-12: Appointment of Dr Jernej Godec as a director on 20 June 2024
- 2024-07-12: Appointment of President Michael Gladstone as a director on 20 June 2024
- 2024-07-11: Termination of appointment of Simon Lempriere Westbrook as a director on 20 June 2024
- 2024-07-11: Termination of appointment of Giovanni Mariggi as a director on 20 June 2024
- 2024-01-16: Accounts for a small company made up to 31 January 2023
- 2023-02-23: Resolutions
- 2023-01-31: Accounts for a small company made up to 31 January 2022
- 2021-04-27: Appointment of Mr Simon Lempriere Westbrook as a director on 21 April 2021
- 2021-04-26: Appointment of Dr Giovanni Mariggi as a director on 21 April 2021
- 2021-01-27: Incorporation

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/crosstalk-therapeutics-13162770